Personal Finance
Simple guides to everyday money decisions. Budgeting, saving, borrowing and bills, explained plainly and without the sales pitch.
-
Inside AbbVie’s High-Stakes Neuro Portfolio and Pipeline Strategy
Following recent neuro-pharmaceutical acquisitions and drug approvals, we assess AbbVie’s pipeline strategy, financial impact, and key shareholder risks.
-
How Ueno Bank’s Collapse Toppled Paraguay’s President and Shook Financial Trust
A digital lender serving 60% of adults failed amid insider-lending allegations, triggering a deposit freeze, mass protests, and the impeachment of President…
-
Why Insurers Send Their Own Nurses to Deny Long-Term Care Claims
After 23 years of premiums, a policyholder’s doctor confirmed she needed help bathing and dressing, but an insurer’s nurse scored her as…
-
US I-Bonds Hit 5.51% Rate, Highest Fixed Component in Two Decades
New Series I savings bonds offer a 1.40% fixed rate, the highest since 2006, as inflation remains sticky and savers seek tax-advantaged…
-
Bristol Myers Squibb vs Vertex: Investment Merits Compared Ahead of 2027
Analysis of financial performance and sector trends pits steady value Bristol Myers Squibb against high-growth Vertex Pharmaceuticals for personal finance readers ahead…
-
The $1,500-a-Year GLP-1 Drug Threat to Retirement Savings
Half of GLP-1 users face choosing medication over retirement savings as out-of-pocket costs top $1,500 annually.
-
Lenacapavir PrEP Costs $42,250 a Year in the U.S. Versus $60 for Generic Pills
The twice-yearly injection keeps 86% of users adherent versus 46% for daily pills, but the wholesale price gap exceeds $42,000 annually for…
-
Star Health’s ₹780 Crore Cancer Payouts Signal Rising Claims Burden for Policyholders
Insurer settles 85,900 cancer claims in H1 FY27, with women and the 51-60 age group driving a 17% surge in payouts.
-
How Missing Bank Statements Trigger Medicaid Denials and $41,000 Bills for Nursing Home Residents
A nursing home files a Medicaid application as a courtesy but omits three bank statements, leaving the family liable for four months…
-
Retirees Can Sidestep New Senior Deduction Cliff by Using Roth Withdrawals
A 2026 tax rule phases out a $12,000 deduction for couples earning over $150,000, but tax-free Roth IRA distributions do not count…
-
Claude’s New Personal Finance Tool Lets Users Spot Spending Leaks via Chat
Anthropic’s new feature connects to bank accounts via Plaid, allowing users to ask conversational questions to categorize spending and flag duplicate charges.
-
Why ACA Premiums Are Rising Again in 2027
Double-digit premium hikes return as federal subsidies expire and healthcare costs climb, leaving middle-income families facing higher bills and fewer options.
-
Bank of England Raises Interest Rate
The Bank of England raises interest rates to 4% to control rising inflation driven by global energy prices
-
How a $310,000 Investment Gain Can Boost Medicare Premiums for Retirees
A retiree’s capital gains from selling investments can trigger higher Medicare Part B premiums two years later, a surprise cost many overlook.
-
Inovio’s First FDA Approval Tests Whether DNA Medicines Can Pay Off for Retail Investors
Voceryq’s accelerated approval for a rare throat disease gives the Plymouth Meeting biotech its first product revenue, but confirmatory trials and a…
-
High-Yield Savings Rates Reach 4.70% on November 3
New rates up to 4.70% offer a real return on cash reserves, far outpacing the national average of 0.38% and protecting savings…
-
UK Mortgage Market: 2.3 Million Households Face £3,600 Annual Repayment Jump as Fixed Deals Expire
Homeowners rolling off 2022 five-year fixes confront rates above 6% while first-time buyers access a new 2.5% deposit government equity loan scheme.
-
Personal Factors Driving Cancer Biomarker Decisions and Patient Outcomes
Gosselaar’s campaign highlights how personal health history and financial access shape biomarker testing choices and treatment precision.
-
RBA Hike to 4.85% Adds $107 to Monthly Mortgage Repayments for Homeowners
The fifth 2026 rate lift hits an 18-year high, intensifying pressure on 3.3 million Australian households as inflation remains stubbornly above target.
-
Affluent Investors Over 60 Face Tax Risks When Splitting Assets
Affluent retirees over 60 must navigate complex tax implications when dividing their wealth, with Roth conversions and 401(k) withdrawals posing significant financial…
-
Nicole Eggert’s Cancer Bills and a Trial That Cut Financial Toxicity for Patients
Despite insurance, out-of-pocket costs and lost wages create fiscal survival challenges for patients, as seen in Nicole Eggert’s battle.
-
Why Retirees Must Shift Emergency Fund Strategies Beyond Standard Three-Month Rules
Retirees face unique spending shocks like home repairs and medical costs, requiring a shift from salary-based savings to portfolio-based liquidity buffers.
-
Timekeepers Vote to End Leap Seconds From May 20, 2027, After Years of Software Outages
Versailles, October 16 — Global timekeepers have voted to abolish leap seconds by May 20, 2027, ending a decades-long practice of adjusting…
-
Why Personal Bankruptcies Jumped 11% Despite Economic Growth
Rising credit costs and eroded savings are driving more Americans to bankruptcy even as GDP expands and unemployment remains low.
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992